Novartis AG Profit Margin

Novartis AG (NVSEF) currently reports a profit margin of 23.09% as of June 2026. That compares with 25.0% in the prior-year period — down 7.6% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Novartis AG's profit margin history and peer comparisons.

Novartis AG's profit margin decreased from 25.0% to 23.09% — a 7.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novartis AG's profit margin of 23.09% is higher than the Healthcare sector average of 13.89%. That is roughly 66.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Novartis AG's current 23.09% should be judged against Healthcare norms (sector average: 13.89%) and against NVSEF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 23.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Novartis AG, and consider following NVSEF for alerts when major investors trade the stock.